Health Care Specialist Launches New PE Fund

Cormorant Asset Management is the latest to raise a new fund targeting private life sciences and biopharma companies.

Stephen Taub August 4, 2021

Bihua Chen, CEO of Cormorant Asset Management.

(Alex Flynn/Bloomberg)

A little-known life sciences and biopharma hedge fund specialist is launching its fourth private equity fund.Cormorant Asset Management disclosed in a regulatory filing it has raised nearly $253 million from 34 investors for Cormorant Private Healthcare Fund IV.It is targeting a total of $400 million,

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.12.03 build:2025-12-12 Login